Neptune Technologies & Bioressources, Inc.
http://www.neptunebiotech.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Neptune Technologies & Bioressources, Inc.
Swanson Vision Defense, Se-cure Femarelle: Health And Wellness Industry News
DSM stirs gut health play with BioCare; Strength coach market for Neptune's Omega Drive; Nutranext corporate brand for Wellnext; and more news in brief.
Neptune, Aker BioMarine Bury Patent Hatchet
The firms say their patent cross-licensing agreement ends all outstanding litigation. Aker gets access to Neptune's composition patents for $10m over a period of 15 months, and Neptune has rights to Aker's select krill oil-related patent portfolio for $4m.
Industry Roundup: Carlyle Backs Pharma Venture, Nutranomics CEO Returns
NSF adds 'next generation' DNA ID service; Dietary Guidelines updated; NPA in anti-internet tax coalition; GNC hires financial communications firm; and more news in brief.
Device/Diagnostics Quarterly Deal Statistics, Q2 2015
At $1.8 billion, Q2 device financing nearly doubled the Q1 total, mainly from an increase in IPOs and early VC rounds, and acquisitions were slightly higher at $4.7 billion. Diagnostics funding also increased to $784 million from Q1's $597 million, and Danaher's monster $13.8 billion buy of life sciences company Pall headlined the second quarter's $15.6 billion total in diagnostics M&A activity.
Company Information
- Industry
-
Pharmaceuticals
- Nutraceuticals
- OTC, Consumer
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
- Other Names / Subsidiaries
-
- Acasti Pharma Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice